Pediatric Nutrition in Practice

(singke) #1

Inborn Errors of Metabolism 233


3


liver and muscle, and disorders of glycogen deg-
radation may affect the liver or muscle or both
[14]. The liver GSD include GSD I and the he-
patic presentation of GSD III [15]. Typical meta-
bolic features are lactic acidaemia and hypogly-
caemia. Variable organ dysfunction, most fre-
quently hepatomegaly, occurs. The goal of
treatment is to maintain normoglycaemia, pre-
vent hypoglycaemia and prevent secondary
complications. Treatments include frequent
meals, cornstarch supplementation and/or con-
tinuous overnight tube feeding to avoid hypo-
glycaemia. In GSD I, allopurinol reduces uric
acid levels in the blood to prevent gout and kid-
ney stones [14].


Conclusions


  • The treatment goal for all IEM is to achieve
    optimal development and nutritional status
    during childhood, and maximal indepen-
    dence, social integration and self-esteem in
    adolescence and adulthood

  • All conditions require diligent care, and IEM
    are best managed by a multidisciplinary team
    led by a physician

  • Attentive nutritional support with the provi-
    sion of macronutrients and micronutrients to
    meet dietary reference values/requirements is
    essential

  • Frequent monitoring of growth, nutritional
    intake, development and biochemical control
    is necessary


11 Bouteldja N, Timson DJ: The biochemi-
cal basis of hereditary fructose intoler-
ance. J Inherit Metab Dis 2010; 33: 105–
112.
12 Steinmann B, Santer R: Disorders of
fructose metabolism; in Saudubray JM,
van den Berghe G, Walter JH (eds): In-
born Metabolic Diseases: Diagnosis and
Treatment, ed 5. Berlin, Springer, 2012,
pp 157–165.
13 van den Berghe G: Disorders of gluco-
neogenesis. J Inherit Metab Dis 1996; 19:
470–477
14 Laforet P, Weinstein DA, Smit PA: The
glycogen storage diseases and related
disorders; in Saudubray JM, van den
Berghe G, Walter JH (eds): Inborn Meta-
bolic Diseases: Diagnosis and Treat-
ment, ed 5. Berlin, Springer, 2012, pp
115–116.
15 Kishnani PS, Austin SL, Arn P, Bali DS,
Boney A, Case LE, Chung WK, Desai
DM, El-Gharbawy A, Haller R, Smit GP,
Smith AD, Hobson-Webb LD, Wechsler
SB, Weinstein DA, Watson MS; ACMG:
Glycogen storage disease type III diag-
nosis and management guidelines. Gen-
et Med 2010; 12: 446–463.

References

1 Dixon M: Emergency regimens; in Shaw
V, Lawson M (eds): Clinical Paediatric
Dietetics, ed 3. Oxford, Blackwell, 2007,
pp 375–389.
2 Hoffmann GF, Nyhan WL, Zschocke J,
Kahler SG, Mayatepek E: Inherited Met-
abolic Diseases: A Clinical Approach.
Philadelphia, Lippincott Williams &
Wilkins, 2002.
3 de Baulny HO, Dionisi-Vici C, Wendel
U: Branched-chain organic acidurias/
acidaemias; in Saudubray JM, van den
Berghe G, Walter JH (eds): Inborn Meta-
bolic Diseases: Diagnosis and Treat-
ment, ed 5. Berlin, Springer, 2012, pp
278–296.
4 MacDonald A, White F, Dixon M: Ami-
no acid disorders; in Shaw V (ed): Clini-
cal Paediatric Dietetics, ed 4. Oxford,
Blackwell, 2014, in press.
5 Zschocke J, Hoffmann GF: Vademecum
Metabolicum: Diagnosis and Treatment
of Inborn Errors of Metabolism, ed 3.
Friedrichsdorf, Milupa Metabolics,
2011.
6 WHO/FAO/UNU: Protein and amino
acid requirements in human nutrition:
report of a joint WHO/FAO/UNU expert
consultation. WHO Technical Report
Series, vol 935. Geneva, WHO, 2007.


7 Adam S, Champion H, Daly A, Dawson
S, Dixon M, Dunlop C, Eardley J, Evans
S, Ferguson C, Jankowski C, Lowry S,
MacDonald A, Maritz C, Micciche A,
Robertson L, Stafford J, Terry A, Thom
R, van Wyk K, Webster D, White FJ,
Wildgoose J; British Inherited Metabolic
Diseases Group (BIMDG) Dietitian’s
Group: Dietary management of urea
cycle disorders: UK practice. J Hum
Nutr Diet 2012; 25: 398–404.
8 Lanpher BC, Gropman A, Chapman KA,
Lichter-Konecki U, Urea Cycle Disor-
ders Consortium, Summar ML: Urea
cycle disorders overview; in Pagon RA,
Adam MP, Bird TD, Dolan CR, Fong CT,
Stephens K (eds): GeneReviews TM. Se-
attle, University of Washington, Seattle,
2003, updated 2011.
9 Lang TF: Adult presentations of medi-
um-chain acyl-CoA dehydrogenase defi-
ciency (MCADD). J Inherit Metab Dis
2009; 32: 675–683.
10 Elsas LJ: Galactosemia; in Pagon RA,
Adam MP, Bird TD, Dolan CR, Fong CT,
Stephens K (eds): GeneReviews TM. Se-
attle, University of Washington, Seattle,
2000, updated 2010.

Koletzko B, et al. (eds): Pediatric Nutrition in Practice. World Rev Nutr Diet. Basel, Karger, 2015, vol 113, pp 226–233
DOI: 10.1159/000360344

Free download pdf